Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00467922 · ClinicalTrials.gov registry record · Phase 3
An Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic Colectomy
A Phase 3 study of Ulcerative Colitis and Crohn's Disease, sponsored by Corewell Health West.
- Completed
- Registry status
- Phase 3
- Development phase
- 69
- Enrollment target
- 1
- Study location
NCT00467922 is a Phase 3 study of Ulcerative Colitis and Crohn's Disease that has completed, run by Corewell Health West. The registered enrollment target is 69 participants, below the 2,057-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00467922, a Phase 3 study of Ulcerative Colitis and Crohn's Disease, has completed, sponsored by Corewell Health West.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 69 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to find out if guided fluid administration with the esophageal monitor is superior to standard fluid administration and whether use of the hetastarch or lactated ringers offers different benefits with respect to length of stay in the hospital after hand-assisted colorectal surgery.
Conditions Studied
Interventions
- DRUG Lactated Ringers
- DRUG Hextend
Study Locations (1)
Michigan
- Spectrum Health - Grand Rapids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2007-05 |
| Est. Completion | 2009-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00467922
The ClinicalTrials.gov registry entry for NCT00467922 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,057-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (97% lower). The listed sponsor is Corewell Health West, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Ulcerative Colitis appearing as the primary indexed condition, and to 2 interventions - of which Lactated Ringers is the first listed.
NCT00467922 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT00467922 about?
NCT00467922 is a clinical study titled "An Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic Colectomy". The purpose of this study is to find out if guided fluid administration with the esophageal monitor is superior to standard fluid administration and whether use of the hetastarch or lactated ringers offers different benefits with respect to length of stay in the hospital after hand-assisted colorect...
What is the current status of trial NCT00467922?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 69 participants. The study started on 2007-05. Estimated completion is 2009-10.
What conditions does trial NCT00467922 study?
This clinical trial studies the following conditions: Ulcerative Colitis, Crohn's Disease, Colon Cancer, Rectal Cancer, Diverticulitis.
What interventions are being tested in trial NCT00467922?
The interventions under investigation include: Lactated Ringers (DRUG), Hextend (DRUG).
Who is sponsoring clinical trial NCT00467922?
This trial is sponsored by Corewell Health West, which has 38 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00467922 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ulcerative Colitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
RECRUITING · Phase 3
-
A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab
RECRUITING · Phase 3
-
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
RECRUITING · Phase 3
-
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
RECRUITING · Phase 3
-
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
RECRUITING · Phase 3
-
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
RECRUITING · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.